APA (7th ed.) Citation

Junichi Okada, Eijiro Yamada, Yawara Niijima, Shuichi Okada, & Masanobu Yamada. (2019). Comparison of serum amylase level between dipeptidyl peptidase-4 inhibitor and GLP-1 analog administration in patients with type 2 diabetes mellitus. BMC.

Chicago Style (17th ed.) Citation

Junichi Okada, Eijiro Yamada, Yawara Niijima, Shuichi Okada, and Masanobu Yamada. Comparison of Serum Amylase Level Between Dipeptidyl Peptidase-4 Inhibitor and GLP-1 Analog Administration in Patients with Type 2 Diabetes Mellitus. BMC, 2019.

MLA (9th ed.) Citation

Junichi Okada, et al. Comparison of Serum Amylase Level Between Dipeptidyl Peptidase-4 Inhibitor and GLP-1 Analog Administration in Patients with Type 2 Diabetes Mellitus. BMC, 2019.